2100 København Ø
Ever since my first experience with organic chemistry as an undergraduate, I have been spellbound with this field of research: The ability of mankind to synthesize any compound of interest and hereafter investigate how a structural change affects its biological activity. The intellectual aspect of rational drug design and synthesis is to me captivating and motivates me every day I go to work.
My passion for natural science made it easy for me to choose my undergraduate studies as a chemical engineer with special focus on organic synthesis and quantum chemistry. My eager to learn more and understand the fundamentals of organic chemistry drove me to pursue a 2-year master study at Florida State University (FSU) in the USA. Accepting an offer of full tuition-waiver and a teaching position at FSU, those two years of intensive study made it clear to me that I wanted to establish a research group in academia within the field of organic and medicinal chemistry.
Returning to my home country for a PhD study in organic chemistry/medicinal chemistry was an easy choice for me. The topic of my thesis was new ligands for the glutamat receptors - a fascinating field within CNS research! Changing my focus for a while, I chose to do my postdoc at DTU in Denmark within organometallic chemistry developing new methodology.
My determinacy to pursue an academic career prompted me to apply for a three-year Assistant Professorship through the Danish Research Foundation, and was granted this in 2003 within the field of glutamatergic neurotransmission.
In 2006, I was promoted to Associate Professor and established my my own research group. We focus on development of new methodology relevant for medicinal chemistry as well as discover novel tool compounds for elucidating disease mechanisms in the CNS.